Histone marks CUT&Tag libraries in PDAC PDO
To elucidate the epigenetic events, particularly the dynamic alterations in chromatin states during the development of gemcitabine resistance in pancreatic cancer PDO, both the parental POD and the gemcitabine-resistant counterparts, PDO-R, were employed for mapping of the histone modification landscape. The CUT&amp;Tag-seq technology was used for precise detection of histone marks, including H3K4me1 (associated with enhancers), H3K27ac (related to active enhancers and promoters), H3K4me3 (linked to PolII-bound and CpG-rich promoters), H3K9me3 (associated with heterochromatin regions), and H3K27me3 (indicative of Polycomb inhibition).